Risk factors for visual field progression in the groningen longitudinal glaucoma study: A comparison of different statistical approaches

Journal of Glaucoma

Volumn 21, Issue 9, 2012, Pages 579-585

  Wesselink, Christiaan ^a   Marcus, Michael W ^a   Jansonius, Nomdo M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

glaucoma; methodology; perimetry; progression; risk factor; visual field

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COURSE EVALUATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; VISUAL FIELD; VISUAL FIELD DEFECT;

AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MODELS, STATISTICAL; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; RISK FACTORS; SCANNING LASER POLARIMETRY; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84871091813     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31822543e0     Document Type: Article

References (29)

1. Chauhan BC, Mikelberg FS, Balaszi AG, et al. Canadian Glaucoma Study: risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008;126:1030-1036.
2. Daugeliene L, Yamamoto T, Kitazawa Y. Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol. 1999;237: 105-108. (Pubitemid 29137296)
3. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699-708. (Pubitemid 32522638)
4. Jonas JB, Martus P, Horn FK, et al. Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss. Invest Ophthalmol Vis Sci. 2004;45:2613-2618. (Pubitemid 38998857)
5. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56. (Pubitemid 36401765)
6. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972. (Pubitemid 350016362)
7. Martus P, Stroux A, Budde WM, et al. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am J Ophthalmol. 2005;139: 999-1009. (Pubitemid 40813310)
8. Musch DC, Gillespie BW, Lichter PR, et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200-207.
9. Nakagami T, Yamazaki Y, Hayamizu F. Prognostic factors for progression of visual field damage in patients with normaltension glaucoma. Jpn J Ophthalmol. 2006;50:38-43. (Pubitemid 43201032)
10. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627-1635. (Pubitemid 39179673)
11. Spry PG, Sparrow JM, Diamond JP, et al. Risk factors for progressive visual field loss in primary open angle glaucoma. Eye. 2005;19:643-651. (Pubitemid 40895477)
12. Stewart WC, Kolker AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 2000;130:274-279.
13. Suzuki Y, Shirato S, Adachi M, et al. Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis. Graefes Arch Clin Exp Ophthalmol. 1999;237:463-467. (Pubitemid 29253538)
14. Tezel G, Siegmund KD, Trinkaus K, et al. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol. 2001;119:813-818. (Pubitemid 32530309)
15. Wesselink C, Heeg GP, Jansonius NM. Glaucoma monitoring in a clinical setting: glaucoma progression analysis versus nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study. Arch Ophthalmol. 2009;127: 270-274.
16. Heeg GP, Blanksma LJ, Hardus PL, et al. The Groningen Longitudinal Glaucoma Study. I: baseline sensitivity and specificity of the frequency doubling perimeter and the GDx nerve fibre analyser. Acta Ophthalmol Scand. 2005;83:46-52. (Pubitemid 40326420)
17. Katz J, Sommer A, Gaasterland DE, et al. Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol. 1991;109:1684-1689.
18. Jansonius NM. Bayes' theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value. Graefes Arch Clin Exp Ophthalmol. 2005;243: 433-437. (Pubitemid 40823216)
19. Allison PD. Binary Logistic Analysis: Details and Options. In: Allison PD, ed. Logistic Regression Using SAS: Theory and Application. Cary, NC: SAS Institute Inc. 2005:31-80.
20. Medeiros FA, Alencar LM, Zangwill LM, et al. Prediction of functional loss in glaucoma from progressive optic disc damage. Arch Ophthalmol. 2009;127:1250-1256.
21. Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. 1999;106:2010-2015.
22. Wu SY, Nemesure B, Leske MC. Refractive errors in a black adult population: the Barbados Eye Study. Invest Ophthalmol Vis Sci. 1999;40:2179-2184. (Pubitemid 29418370)
23. Grodum K, Heijl A, Bengtsson B. Refractive error and glaucoma. Acta Ophthalmol Scand. 2001;79:560-566. (Pubitemid 33134110)
24. Wong TY, Klein BE, Klein R, et al. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology. 2003;110:211-217. (Pubitemid 36068747)
25. Czudowska MA, Ramdas WD, Wolfs RCW, et al. Incidence of glaucomatous visual field loss: a 10-year follow-up from the Rotterdam Study. Ophthalmology. (In press).
26. Sultan MB, Mansberger SL, Lee PP. Understanding the importance of IOP variables in glaucoma: a systematic review. Surv Ophthalmol. 2009;54:643-662.
27. AGIS investigators. Advanced Glaucoma Intervention Study. 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445-1455.
28. Heijl A, Leske MC, Bengtsson B, et al. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003;81:286-293. (Pubitemid 36806269)
29. Heijl A, Lindgren G, Lindgren A, et al. Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: Statpac 2. In: Mills RP, Heijl A, eds. Perimetry Update 1990/1. New York: Kugler; 1990: 305-315.